Last reviewed · How we verify
NCT07236840: NEMO
Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
trial testing Neurological assessment in CNS Tumor in 600 participants. Currently enrolling.
1 November 2027
Quick facts
| Lead sponsor | Tata Memorial Centre |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 20 February 2026 |
| Primary completion | 1 November 2027 |
| Estimated completion | 5 November 2027 |
| Sites | 1 location across India |
Drugs / interventions tested
- Neurological assessment
Conditions studied
- CNS Tumor — all drugs for CNS Tumor →
- Artificial Intelligence (AI) — all drugs for Artificial Intelligence (AI) →
- Glioma — all drugs for Glioma →
- Digital Health — all drugs for Digital Health →
Sponsor
Tata Memorial Centre — full company profile →
Who can join
5 and older, any sex, with CNS Tumor or Artificial Intelligence (AI). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions. The main questions it aims to answer are: 1. Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks. 2. Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration. Participants will: 1. Use the Iskhaa mobile application to perform guided self-neurological examinations following pre-recorded video instructions. 2. Complete EORTC QLQ-C30 and BN20 questionnaires for quality of life assessment. 3. Record and upload videos (e.g., speech, walking, limb movements) using their mobile camera for analysis. 4. In Phase 1 (onsite), 100 participants will use the app under supervision to ensure usability and accuracy. 5. In Phase 2 (offsite), 500 participants will use the app independently at home for monthly self-assessments, with reminders and follow-up support. 6. Continue routine clinic visits every 3-6 months and imaging every 6-12 months as per standard clinical care. The study will compare app-recorded data with physician assessments to determine agreement and validity of remote neurological monitoring using artificial intelligence analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07236840
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neurological assessment
Trials testing the same drug.
- NCT05808504 — Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease · NA · recruiting
Other recruiting trials for CNS Tumor
Currently open trials in the same condition.
- NCT05982691 — Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors · recruiting
- NCT04732065 — ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors · Phase 1 · recruiting
- NCT03838042 — INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies · Phase 1, PHASE2 · recruiting
Other Tata Memorial Centre trials
Trials by the same sponsor.
- NCT06492486 — Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow · Phase 2 · not yet recruiting
- NCT07338539 — BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM · Phase 2 · recruiting
- NCT07395635 — Phase II Trial of Immunonutrition in Hepatectomy · NA · recruiting
- NCT07338526 — Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT) · NA · recruiting
- NCT06831461 — Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07236840 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tata Memorial Centre
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07236840.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing